NYU LANGONE HOSPITALS — History
CCN 330214 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$7.2B
Latest Revenue (FY2022)
+7.4%
Revenue CAGR (3yr)
-7.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $6.3B | $6.6B | $7.2B | +9.1% | +7.4% |
| Operating Expenses | $6.6B | $6.9B | $7.8B | +13.1% | +8.9% |
| Operating Margin | -5.0% | -4.0% | -7.8% | -94.8% | +0.0% |
| Net Income | $-315M | $-267M | $-568M | -112.5% | +0.0% |
| Licensed Beds | 1,518 | 1,571 | 1,618 | +3.0% | +3.2% |
| Total Patient Days | 456,558 | 457,641 | 501,215 | +9.5% | +4.8% |
| Medicare Day % | 29% | 29% | 28% | -2.1% | -1.9% |
| Medicaid Day % | 7% | 7% | 7% | -4.7% | +0.7% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.4% ($6.3B → $7.2B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.4%
This Hospital
+7.6%
State Avg
Latest Margin
-7.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $7.7B | -9.3% |
| FY2024 (proj) | $8.2B | -10.7% |
| FY2025 (proj) | $8.7B | -12.1% |